ncr100
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2023 (NCT06049342)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07139431 | Phase 1 | Aug 29, 2025 | Nuwacell Biotechnologies Co., Ltd. |
| NCT06741098 | Phase 1/Phase 2 (Phase 2) | Feb 20, 2025 | Jiao Tong University, Nuwacell Biotechnologies Co., Ltd. |
| NCT06049342 | Phase 1 | Oct 31, 2023 | Capital Medical University, Jiao Tong University, Nuwacell Biotechnologies Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nuwacell Biotechnologies Co., Ltd. | For profit | 3 | 3 | 2 | 2023 |
| Jiao Tong University | Academic/Hospital | 2 | 0 | 2 | 2023 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1